- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2018
- Public Summary Document (PSD) March 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2018 PBAC Meeting - Word
Ranolazine – March 2018
Ranolazine: Tablet (modified release), 375 mg, 500 mg, 750 mg; Ranexa®
Last updated
29 June 2018